Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData EP News Bureau Sep 5, 2023 The latest data from the final analysis of the Phase II OCEAN(a)-DOSE study showed that olpasiran reduced Lp(a) levels in patients…
Amgen announces positive phase-II data for investigational Olpasiran in adults with elevated… EP News Bureau Jun 2, 2022 The study showed significant and sustained reduction in lipoprotein(a) during treatment period
